JACOB GERVAIS: Open Payments
NPI 1548999766 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 31 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $153 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $253 |
| GENZYME CORPORATION | 5 | $126 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Inspire Medical Systems, Inc. | 3 | $84 |
| Optinose US, Inc. | 3 | $64 |
| Stryker Corporation | 2 | $39 |
| Hikma Pharmaceuticals USA | 1 | $20 |
Products named: NUCALA, DUPIXENT, INSPIRE, Xhance, AUDION ET DILATION SYSTEM, Ryaltris.
Industry payments across AZ — which companies pay providers there.
